WebApr 19, 2024 · The median serum PSA prior to and after PSMA PET directed therapy was 1.01 ng/ml and 0.39 ng/ml, respectively. The pooled proportion of decrease of PSA and complete biochemical response are ... WebMar 4, 2024 · There has been a growing interest in metastases-directed therapy (e.g. EBRT) mainly to postpone ADT-related adverse effects or even cure selected patients with mainly limited number of metastases (five or less), considered oligometastatic prostate cancer. 38 The use of PSMA-RLT appears to be quite effective in this setting, as was shown in a ...
PSMA Radiopharmaceutical Effective against Prostate Cancer
WebMay 10, 2024 · However, the type of imaging that best defines oligometastatic PCa for the purpose of metastasis-directed therapy is debated . PSMA-based literature on this topic is mostly retrospective, and the randomized phase 2 ORIOLE (Observation vs. Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer) study is the first clinical trial on ... WebJun 23, 2024 · Prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) is a promising new therapeutic approach to treat metastatic prostate cancer. This tumor-specific treatment is directed against PSMA, which is overexpressed in prostate cancer cells. to have a row with someone
ASCO 2024: PSMA-Targeted Radioligand Therapy …
WebMar 16, 2024 · Illuccix is a kit for the preparation of gallium-68 (68Ga) gozetotide (also known as PSMA-11) injection, a radioactive diagnostic agent indicated for positron emission tomography (PET) of... WebApr 12, 2024 · As prostate cancer progresses, tumors lose the androgen receptor (AR) on which initial treatment is based. Oftentimes, such patients also lose expression prostate … Web1 day ago · Currently, prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals are the only clinically available molecules for theranostics of … to have a seat